Cargando…
Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
One of the major challenges in the treatment of cancer are differential responses of patients to existing standard of care anti-cancer drugs. These differential responses may, in part, be due to a diverse range of genomic, epigenomic, proteomic, and metabolic alterations among individuals suffering...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794771/ https://www.ncbi.nlm.nih.gov/pubmed/33396714 http://dx.doi.org/10.3390/ijms22010305 |